Amyloid Triggers Extensive Cerebral Angiogenesis Causing Blood Brain Barrier Permeability and Hypervascularity in Alzheimer's Disease
Open accessThe DOI matches its Crossref record; 72 of the 73 references it cites were found in a registry or an index.
Abstract
Evidence of reduced blood-brain barrier (BBB) integrity preceding other Alzheimer's disease (AD) pathology provides a strong link between cerebrovascular angiopathy and AD. However, the "Vascular hypothesis", holds that BBB leakiness in AD is likely due to hypoxia and neuroinflammation leading to vascular deterioration and apoptosis. We propose an alternative hypothesis: amyloidogenesis promotes extensive neoangiogenesis leading to increased vascular permeability and subsequent hypervascularization in AD. Cerebrovascular integrity was characterized in Tg2576 AD model mice that overexpress the human amyloid precursor protein (APP) containing the double missense mutations, APPsw, found in a Swedish family, that causes early-onset AD. The expression of tight junction (TJ) proteins, occludin and ZO-1, were examined in conjunction with markers of apoptosis and angiogenesis. In aged Tg2576 AD mice, a significant increase in the incidence of disrupted TJs, compared to age matched wild-type littermates and young mice of both genotypes, was directly linked to an increased microvascular density but not apoptosis, which strongly supports amyloidogenic triggered hypervascularity as the basis for BBB disruption. Hypervascularity in human patients was corroborated in a comparison of postmortem brain tissues from AD and controls. Our results demonstrate that amylodogenesis mediates BBB disruption and leakiness through promoting neoangiogenesis and hypervascularity, resulting in the redistribution of TJs that maintain the barrier and thus, provides a new paradigm for integrating vascular remodeling with the pathophysiology observed in AD. Thus the extensive angiogenesis identified in AD brain, exhibits parallels to the neovascularity evident in the pathophysiology of other diseases such as age-related macular degeneration.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Inflammation affects the BBB,126”
From Mechanisms of sporadic cerebral small vessel disease: insights from neuroimaging (2013) · cites this paper as [126]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“we were unable to demonstrate a decrease in claudin‐5 in AD, as previously reported [127]”
From Gliovascular alterations in sporadic and familial Alzheimer's disease: APOE3 Christchurch homozygote glioprotection (2023) · cites this paper as [127]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED ARTICLE: A specific amyloid-β protein assembly in the brain impairs memory
Lesné, S., Koh, M. T., Kotilinek, L., Kayed, R., Glabe, C. G., Yang, A., Gallagher, M., & Ashe, K. H. (2006) · Nature · doi:10.1038/nature04533 · Cited by 2,769 · cited 1×
“Another potential mediator of cerebrovascular disruption in AD is a highly toxic dodecameric 56 kDa abeta oligomer, referred to as “abeta*56” that has been directly implicated in memory loss in Tg2576 mice”
BackgroundRetractedCleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4
LAEMMLI, U. K. (1970) · Nature · doi:10.1038/227680a0 · Cited by 249,961
Tumor Angiogenesis and Metastasis — Correlation in Invasive Breast Carcinoma
Weidner, N., Semple, J. P., Welch, W. R., & Folkman, J. (1991) · New England Journal of Medicine · doi:10.1056/nejm199101033240101 · Cited by 5,627 · cited 1×
“Areas within the brain section containing high density (‘‘hotspots’’) [39] CD105 staining were imaged using the 206/0.”
MethodStructure and function of the blood–brain barrier
Abbott, N. J., Patabendige, A. A. K., Dolman, D. E. M., Yusof, S. R., & Begley, D. J. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.07.030 · Cited by 5,185 · cited 1×
“The physical seal of the BBB is maintained by several different interendothelial tight junctional complexes (reviewed by [31,32]) comprised of a variety of plasma membrane spanning proteins (like occludin), scaffold cytoplasmic proteins (like ZO-1) and the actin cytoskeleton.”
BackgroundCorrelative Memory Deficits, Aβ Elevation, and Amyloid Plaques in Transgenic Mice
Hsiao, K., Chapman, P., Nilsen, S., Eckman, C., Harigaya, Y., Younkin, S., Yang, F., & Cole, G. (1996) · Science · doi:10.1126/science.274.5284.99 · Cited by 4,210 · cited 2×
“These mice express human APP695 containing the Swedish missense mutations (K670N/M671L) or APPsw [33], under control of the hamster prion protein promoter (Taconic).”
BackgroundMethodDiabetes mellitus and the risk of dementia: The Rotterdam Study
Ott, A., Stolk, R. P., van Harskamp, F., Pols, H. A. P., Hofman, A., & Breteler, M. M. B. (1999) · Neurology · doi:10.1212/wnl.53.9.1937 · Cited by 2,175
APP Processing and Synaptic Function
Kamenetz, F., Tomita, T., Hsieh, H., Seabrook, G., Borchelt, D., Iwatsubo, T., Sisodia, S., & Malinow, R. (2003) · Neuron · doi:10.1016/s0896-6273(03)00124-7 · Cited by 1,644
Kivipelto, M., Helkala, E.-L., Laakso, M. P., Hänninen, T., Hallikainen, M., Alhainen, K., Soininen, H., Tuomilehto, J., & Nissinen, A. (2001) · BMJ · doi:10.1136/bmj.322.7300.1447 · Cited by 1,618 · cited 1×
“However, recent studies have found that vascular risk factors and neurovascular dysfunction associated with hypotension, hypertension [6,7], cholesterol levels, type II diabetes mellitus [8], smoking [9] and oxidative stress [10] play integral roles in the pathogenesis of AD [11].”
BackgroundRAGE mediates amyloid-β peptide transport across the blood-brain barrier and accumulation in brain
Deane, R., Du Yan, S., Submamaryan, R. K., LaRue, B., Jovanovic, S., Hogg, E., Welch, D., Manness, L., Lin, C., Yu, J., et al. (2003) · Nature Medicine · doi:10.1038/nm890 · Cited by 1,611 · cited 2×
“dysfunction leads to neurodegenerative changes including accumulation of Ab [27,28], neuroinflammation [29] and ensuing”
BackgroundResultBell, R. D., Winkler, E. A., Sagare, A. P., Singh, I., LaRue, B., Deane, R., & Zlokovic, B. V. (2010) · Neuron · doi:10.1016/j.neuron.2010.09.043 · Cited by 1,448
Obesity and Vascular Risk Factors at Midlife and the Risk of Dementia and Alzheimer Disease
Kivipelto, M., Ngandu, T., Fratiglioni, L., Viitanen, M., Kåreholt, I., Winblad, B., Helkala, E.-L., Tuomilehto, J., Soininen, H., & Nissinen, A. (2005) · Archives of Neurology · doi:10.1001/archneur.62.10.1556 · Cited by 1,291 · cited 1×
“However, recent studies have found that vascular risk factors and neurovascular dysfunction associated with hypotension, hypertension [6,7], cholesterol levels, type II diabetes mellitus [8], smoking [9] and oxidative stress [10] play integral roles in the pathogenesis of AD [11].”
BackgroundCerebral amyloid angiopathy. A critical review.
Vinters, H. V. (1987) · Stroke · doi:10.1161/01.str.18.2.311 · Cited by 1,071
Microglia and neuroinflammation: a pathological perspective
Streit (2004) · Journal of Neuroinflammation · doi:10.1186/1742-2094-1-14 · Cited by 1,039
Blood–brain barrier: Ageing and microvascular disease – systematic review and meta-analysis
Farrall, A. J., & Wardlaw, J. M. (2009) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.07.015 · Cited by 882 · cited 2×
“Furthermore, our animal studies are complimented by magnetic resonance imaging (MRI) and related in vivo imaging studies [23] that show BBB permeability is increased in humans affected with AD.”
BackgroundLRP/Amyloid β-Peptide Interaction Mediates Differential Brain Efflux of Aβ Isoforms
Deane, R., Wu, Z., Sagare, A., Davis, J., Du Yan, S., Hamm, K., Xu, F., Parisi, M., LaRue, B., Hu, H. W., et al. (2004) · Neuron · doi:10.1016/j.neuron.2004.07.017 · Cited by 828
Picomolar Amyloid-β Positively Modulates Synaptic Plasticity and Memory in Hippocampus
Puzzo, D., Privitera, L., Leznik, E., Fà, M., Staniszewski, A., Palmeri, A., & Arancio, O. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.2692-08.2008 · Cited by 740 · cited 1×
“During amyloidogenesis, abeta peptides arise by successive cleavage of unprocessed APP by beta-and gamma-secretases [42,43,44, 45,46,47] and recently, it has come into question whether the large aggregated extracellular abeta plaques, a hallmark of AD pathology, directly cause the neurodegenerative effects in AD.”
BackgroundWeller, R. O., Massey, A., Newman, T. A., Hutchings, M., Kuo, Y.-M., & Roher, A. E. (1998) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65616-7 · Cited by 679
Duce, J. A., Tsatsanis, A., Cater, M. A., James, S. A., Robb, E., Wikhe, K., Leong, S. L., Perez, K., Johanssen, T., Greenough, M. A., et al. (2010) · Cell · doi:10.1016/j.cell.2010.08.014 · Cited by 676
Blood brain barrier: ageing and microvascular disease-systematic review and meta-analysis
Farrall, A. J., & Wardlaw, J. M. (2009) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2009.02.089 · Cited by 639
Amyloid oligomers: formation and toxicity of Aβ oligomers
Sakono, M., & Zako, T. (2010) · The FEBS Journal · doi:10.1111/j.1742-4658.2010.07568.x · Cited by 605 · cited 1×
“and recently, it has come into question whether the large aggregated extracellular abeta plaques, a hallmark of AD pathology, directly cause the neurodegenerative effects in AD. It is emerging that the smaller, more toxic, soluble abeta oligomers may directly initiate disease (reviewed by”
BackgroundCD105 is important for angiogenesis: evidence and potential applications
DUFF, S. E., LI, C., GARLAND, J. M., & KUMAR, S. (2003) · The FASEB Journal · doi:10.1096/fj.02-0634rev · Cited by 556 · cited 2×
“The CD105 expression was not able to distinguish vessels with TJ abnormalities from those without [41], however, the apparent pan-endothelial staining of CD105 was extremely useful as it allowed the quantitation of the density of CD105 staining and thus the microvascular density (MVD), in the entire brain.”
BackgroundMethodOtt, A., Slooter, A., Hofman, A., van Harskamp, F., Witteman, J., Van Broeckhoven, C., van Duijn, C., & Breteler, M. (1998) · The Lancet · doi:10.1016/s0140-6736(97)07541-7 · Cited by 535 · cited 1×
“However, recent studies have found that vascular risk factors and neurovascular dysfunction associated with hypotension, hypertension [6,7], cholesterol levels, type II diabetes mellitus [8], smoking [9] and oxidative stress [10] play integral roles in the pathogenesis of AD [11].”
BackgroundRegulation of APP cleavage by α‐, β‐ and γ‐secretases
Nunan, J., & Small, D. H. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)02076-7 · Cited by 512
Involvement of ROS in BBB dysfunction
Pun, P. B. L., Lu, J., & Moochhala, S. (2009) · Free Radical Research · doi:10.1080/10715760902751902 · Cited by 457 · cited 1×
“ROS from other sources including microglial activation, inflammation, from serum leakage, could also effect BBB integrity [53].”
BackgroundALZHEIMER'S DISEASE: Genetic Studies and Transgenic Models
Price, D. L., Tanzi, R. E., Borchelt, D. R., & Sisodia, S. S. (1998) · Annual Review of Genetics · doi:10.1146/annurev.genet.32.1.461 · Cited by 406 · cited 1×
“AD is characterized by the presence of extracellular neuritic plaques comprised of the amyloid-beta (abeta) peptide and intracellular neurofibrillary tangles comprised of the tau protein [2,3].”
BackgroundTarkowski, E., Issa, R., Sjögren, M., Wallin, A., Blennow, K., Tarkowski, A., & Kumar, P. (2002) · Neurobiology of Aging · doi:10.1016/s0197-4580(01)00285-8 · Cited by 360 · cited 1×
“The pro-angiogenic growth factor VEGF is also induced by these cytokines [59] and is elevated in AD patients [60].”
BackgroundBlood—Brain Barrier Permeability Precedes Senile Plaque Formation in an Alzheimer Disease Model
UJIIE, M., DICKSTEIN, D. L., CARLOW, D. A., & JEFFERIES, W. A. (2003) · Microcirculation · doi:10.1038/sj.mn.7800212 · Cited by 351 · cited 1×
“Blood brain barrier (BBB) dysfunction was initially identified in animal models of AD”
BackgroundSelf-citationPaul, J., Strickland, S., & Melchor, J. P. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20070304 · Cited by 319 · cited 2×
“The origin of BBB dysfunction during AD is not known, but APP expression leading to the generation of abeta may be directly involved in this process as BBB leakiness has been demonstrated in a number of AD transgenic animals models in which forms of APP are overexpressed, including the Tg2576 that overexpresses the hu…”
BackgroundPhysiological roles for amyloid β peptides
Pearson, H. A., & Peers, C. (2006) · The Journal of Physiology · doi:10.1113/jphysiol.2006.111203 · Cited by 286 · cited 1×
“During amyloidogenesis, abeta peptides arise by successive cleavage of unprocessed APP by beta-and gamma-secretases [42,43,44, 45,46,47] and recently, it has come into question whether the large aggregated extracellular abeta plaques, a hallmark of AD pathology, directly cause the neurodegenerative effects in AD.”
BackgroundPlumb, J., McQuaid, S., Mirakhur, M., & Kirk, J. (2002) · Brain Pathology · doi:10.1111/j.1750-3639.2002.tb00430.x · Cited by 262 · cited 1×
“[36].”
Olichney, J. M., Hansen, L. A., Hofstetter, C. R., Grundman, M., Katzman, R., & Thal, L. J. (1995) · Archives of Neurology · doi:10.1001/archneur.1995.00540310076019 · Cited by 246
Efflux and Atherosclerosis: The Clinical and Biochemical Impact of Variations in the ABCA1 Gene
Singaraja, R. R., Brunham, L. R., Visscher, H., Kastelein, J. J. P., & Hayden, M. R. (2003) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000078520.89539.77 · Cited by 245
Has the Amyloid Cascade Hypothesis for Alzheimers Disease been Proved?
Hardy, J. (2006) · Current Alzheimer Research · doi:10.2174/156720506775697098 · Cited by 241 · cited 1×
“The amyloid cascade hypothesis implicates abeta as the key player in the formation of senile plaques and neuronal death [4].”
BackgroundMiravalle, L. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m003154200 · Cited by 217 · cited 1×
“Although, apoptotic endothelial cells were not observed in this study, in vitro evidence does suggest that abeta, especially mutations pertaining to the Dutch mutant, have been shown to induce apoptosis in cultured endothelial cells [21,55,56].”
BackgroundDissection of Hippocampal Dentate Gyrus from Adult Mouse
Hagihara, H., Toyama, K., Yamasaki, N., & Miyakawa, T. (2009) · Journal of Visualized Experiments · doi:10.3791/1543 · Cited by 199
Neurodegeneration and the neurovascular unit
Zlokovic, B. V. (2010) · Nature Medicine · doi:10.1038/nm1210-1370 · Cited by 189 · cited 3×
“The goal of this study was to test the ‘‘Vascular hypothesis’’ of AD [30] that would require evidence of cerebrovascular damage and apoptosis, or the alternative hypothesis, that amyloidogenesis leads directly to angiogenesis and hypervascularization that underlie increased vascular permeability in AD.”
BackgroundResultKumar-Singh, S., Pirici, D., McGowan, E., Serneels, S., Ceuterick, C., Hardy, J., Duff, K., Dickson, D., & Van Broeckhoven, C. (2005) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)62995-1 · Cited by 184 · cited 2×
“The origin of BBB dysfunction during AD is not known, but APP expression leading to the generation of abeta may be directly involved in this process as BBB leakiness has been demonstrated in a number of AD transgenic animals models in which forms of APP are overexpressed, including the Tg2576 that overexpresses the hu…”
BackgroundEndoglin (CD105) and vascular endothelial growth factor as prognostic markers in colorectal cancer
Saad, R. S., Liu, Y. L., Nathan, G., Celebrezze, J., Medich, D., & Silverman, J. F. (2004) · Modern Pathology · doi:10.1038/modpathol.3800034 · Cited by 178 · cited 1×
“CD105 on the other hand has been shown to consistently react with endothelials cells [65], especially those undergoing angiogenesis, and does not react with stromal or inflammatory cells [67,68].”
BackgroundVascular oxidative stress in Alzheimer disease
Zhu, X., Smith, M. A., Honda, K., Aliev, G., Moreira, P. I., Nunomura, A., Casadesus, G., Harris, P. L. R., Siedlak, S. L., & Perry, G. (2007) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2007.01.039 · Cited by 175 · cited 1×
“However, recent studies have found that vascular risk factors and neurovascular dysfunction associated with hypotension, hypertension [6,7], cholesterol levels, type II diabetes mellitus [8], smoking [9] and oxidative stress [10] play integral roles in the pathogenesis of AD [11].”
BackgroundMarco, S., & Skaper, S. D. (2006) · Neuroscience Letters · doi:10.1016/j.neulet.2006.03.047 · Cited by 172 · cited 1×
“[49] demonstrated that abeta 1–42 stimulated endothelial cultures induced aberrant expression of TJ proteins including claudins, occludins and ZO-1.”
BackgroundMechanism of Cerebral β-Amyloid Angiopathy: Murine and Cellular Models
Herzig, M. C., Nostrand, W. E., & Jucker, M. (2006) · Brain Pathology · doi:10.1111/j.1750-3639.2006.tb00560.x · Cited by 169
The enigma of vascular cognitive disorder and vascular dementia
Jellinger, K. A. (2007) · Acta Neuropathologica · doi:10.1007/s00401-006-0185-2 · Cited by 166 · cited 1×
“CAA is associated with degeneration of smooth muscle cells, ischemic white matter damage, fibrinoid necrosis and dementia [19].”
BackgroundRole of Vascular Risk Factors and Vascular Dysfunction in Alzheimer's Disease
Dickstein, D. L., Walsh, J., Brautigam, H., Stockton, S. D., Gandy, S., & Hof, P. R. (2010) · Mount Sinai Journal of Medicine: A Journal of Translational and Personalized Medicine · doi:10.1002/msj.20155 · Cited by 155 · cited 1×
“However, recent studies have found that vascular risk factors and neurovascular dysfunction associated with hypotension, hypertension [6,7], cholesterol levels, type II diabetes mellitus [8], smoking [9] and oxidative stress [10] play integral roles in the pathogenesis of AD [11].”
BackgroundSelf-citationEvidence of angiogenic vessels in Alzheimer’s disease
Desai, B. S., Schneider, J. A., Li, J.-L., Carvey, P. M., & Hendey, B. (2009) · Journal of Neural Transmission · doi:10.1007/s00702-009-0226-9 · Cited by 153 · cited 1×
“AD brains: laminin or von Willerbrand factor expression [34]; integrin aV-b3 expression [70]; and in the APP23 AD mouse”
BackgroundNew Therapeutic Targets in the Neurovascular Pathway in Alzheimer's Disease
Zlokovic, B. V. (2008) · Neurotherapeutics · doi:10.1016/j.nurt.2008.05.011 · Cited by 151 · cited 1×
“The physical seal of the BBB is maintained by several different interendothelial tight junctional complexes (reviewed by [31,32]) comprised of a variety of plasma membrane spanning proteins (like occludin), scaffold cytoplasmic proteins (like ZO-1) and the actin cytoskeleton.”
BackgroundImpaired angiogenesis in a transgenic mouse model of cerebral amyloidosis
Paris, D., Patel, N. S., DelleDonne, A., Quadros, A., Smeed, R., & MULLAN, M. J. (2004) · Neuroscience Letters · doi:10.1016/j.neulet.2004.05.017 · Cited by 144 · cited 1×
“Paris et al [64] noted the Tg2576 mouse to have limited angiogenesis.”
BackgroundCadavid, D., Mena, H., Koeller, K., & Frommelt, R. A. (2000) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/59.9.768 · Cited by 138 · cited 1×
“Vascular accumulation of abeta species 1–42 and abeta species 1–40 in AD is becoming a well-documented risk factor for cerebral hemorrhage, atherosclerosis and arteriosclerosis [14,15,16].”
BackgroundEl-Gohary, Y., Silverman, J. F., Olson, P., Liu, Y. L., Cohen, J., Miller, R., & Saad, R. S. (2007) · American Journal of Clinical Pathology · doi:10.1309/x6nxye57dlue2nq8 · Cited by 129 · cited 2×
“Although there is no consensus in the literature as to which is the ‘‘best’’ marker for studying angiogenesis in the brain, PECAM is not favoured as an angiogenic marker as compared to CD105 [65] since PECAM is not limited to pan-endothelial expression as plasma and inflammatory cells are typically immunolabeled also…”
BackgroundHolton, J. L., Ghiso, J., Lashley, T., Rostagno, A., Guerin, C. J., Gibb, G., Houlden, H., Ayling, H., Martinian, L., Anderton, B. H., et al. (2001) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63993-4 · Cited by 114 · cited 1×
“CAA involves the deposition of abeta within the small blood vessels of the brain and is found within the walls of the leptomeninges and parenchymal arteries, arterioles and capillaries [17,18].”
BackgroundAβ peptide immunization restores blood‐brain barrier integrity in Alzheimer disease
Dickstein, D. L., Biron, K. E., Ujiie, M., Pfeifer, C. G., Jeffries, A. R., & Jefferies, W. A. (2006) · The FASEB Journal · doi:10.1096/fj.05-3956com · Cited by 111
Self-citationHolley, J. E., Newcombe, J., Whatmore, J. L., & Gutowski, N. J. (2009) · Neuroscience Letters · doi:10.1016/j.neulet.2009.12.059 · Cited by 99 · cited 1×
“vasculature [38], images of optimal fluorescent intensity were”
BackgroundShibuya, M. (2009) · FEBS Journal · doi:10.1111/j.1742-4658.2009.07175.x · Cited by 93 · cited 1×
“VEGF directly stimulates endothelial proliferation [61].”
Endoglin (CD105) Expression in Endometrial Carcinoma
Saad, R. S., Jasnosz, K. M., Tung, M. Y., & Silverman, J. F. (2003) · International Journal of Gynecological Pathology · doi:10.1097/01.pgp.0000070852.25718.37 · Cited by 85 · cited 1×
“CD105 on the other hand has been shown to consistently react with endothelials cells [65], especially those undergoing angiogenesis, and does not react with stromal or inflammatory cells [67,68].”
BackgroundFossati, S., Cam, J., Meyerson, J., Mezhericher, E., Romero, I. A., Couraud, P. O., Weksler, B. B., Ghiso, J., & Rostagno, A. (2010) · The FASEB Journal · doi:10.1096/fj.09-139584 · Cited by 82 · cited 3×
“Although, apoptotic endothelial cells were not observed in this study, in vitro evidence does suggest that abeta, especially mutations pertaining to the Dutch mutant, have been shown to induce apoptosis in cultured endothelial cells [21,55,56].”
BackgroundResultCharacteristics of Dyshoric Capillary Cerebral Amyloid Angiopathy
Richard, E., Carrano, A., Hoozemans, J. J., van Horssen, J., van Haastert, E. S., Eurelings, L. S., de Vries, H. E., Thal, D. R., Eikelenboom, P., van Gool, W. A., et al. (2010) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3181fab558 · Cited by 71 · cited 1×
“CAA involves the deposition of abeta within the small blood vessels of the brain and is found within the walls of the leptomeninges and parenchymal arteries, arterioles and capillaries [17,18].”
BackgroundLiving with the enemy: a physiological role for the β-amyloid peptide
Esteban, J. A. (2003) · Trends in Neurosciences · doi:10.1016/j.tins.2003.10.008 · Cited by 66
Gonzalez‐Velasquez, F. J., Kotarek, J. A., & Moss, M. A. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05618.x · Cited by 65 · cited 1×
“[50] demonstrated that smaller abeta 1–40 aggregates induced endothelial cell permeability and the relocalization of ZO-1 to the cytoplasm.”
BackgroundAngiogenic signaling in Alzheimer's disease
Pogue, A. I., & Lukiw, W. J. (2004) · NeuroReport · doi:10.1097/01.wnr.0000130539.39937.1d · Cited by 65 · cited 1×
“First, neuroinflammation is a pathological feature of AD [57] and is associated with the increase in cytokines, like IL-1b, that are capable of inducing angiogenesis [58].”
BackgroundStroke related to cerebral amyloid angiopathy: the significance of systemic vascular disease
Ferreiro, J. A., Ansbacher, L. E., & Vinters, H. V. (1989) · Journal of Neurology · doi:10.1007/bf00314454 · Cited by 55 · cited 1×
“Vascular accumulation of abeta species 1–42 and abeta species 1–40 in AD is becoming a well-documented risk factor for cerebral hemorrhage, atherosclerosis and arteriosclerosis [14,15,16].”
Background(1997) · Biological Chemistry · doi:10.1515/bchm.1997.378.9.937 · Cited by 49 · cited 1×
“Alzheimer’s disease (AD) is a neurodegenerative disorder and is the leading cause of dementia in the elderly [1].”
BackgroundIntratumoral angiogenesis: a new prognostic indicator for stage I endometrial adenocarcinomas?
Giatromanolaki, A. N., Sivridis, E., Koukourakis, M. I., Georgoulias, V., Gatter, K. C., & Harris, A. L. (1999) · PubMed · Cited by 48
Bürger, S., Noack, M., Kirazov, L., Kirazov, E. P., Naydenov, C. L., Kouznetsova, E., Yafai, Y., & Schliebs, R. (2009) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2009.06.011 · Cited by 46 · cited 1×
“in the cortical tissue of 20 month old Tg2576 mice [69] supports”
Backgroundβ amyloid angiogenic activity in vitro and in vivo
Boscolo, E., Folin, M., Nico, B., Grandi, C., Mangieri, D., Longo, V., Scienza, R., Zampieri, P., Conconi, M., Parnigotto, P., et al. (2007) · International Journal of Molecular Medicine · doi:10.3892/ijmm.19.4.581 · Cited by 46 · cited 1×
“Abeta peptides themselves have also been shown to have angiogenic properties [62].”
BackgroundEndogenous amyloidogenesis in long-term rat hippocampal cell cultures
Bertrand, S. J., Aksenova, M. V., Aksenov, M. Y., Mactutus, C. F., & Booze, R. M. (2011) · BMC Neuroscience · doi:10.1186/1471-2202-12-38 · Cited by 40 · cited 1×
“During amyloidogenesis, abeta peptides arise by successive cleavage of unprocessed APP by beta-and gamma-secretases [42,43,44, 45,46,47] and recently, it has come into question whether the large aggregated extracellular abeta plaques, a hallmark of AD pathology, directly cause the neurodegenerative effects in AD.”
BackgroundSchultheiß, C., Blechert, B., Gaertner, F. C., Drecoll, E., Mueller, J., Weber, G. F., Drzezga, A. E., & Essler, M. (2006) · Angiogenesis · doi:10.1007/s10456-006-9030-4 · Cited by 39 · cited 2×
“model beta3-integrin subunit expression [59].”
BackgroundSolito, R., Corti, F., Fossati, S., Mezhericher, E., Donnini, S., Ghiso, J., Giachetti, A., Rostagno, A., & Ziche, M. (2009) · Experimental Cell Research · doi:10.1016/j.yexcr.2008.11.002 · Cited by 39 · cited 2×
“degrees of brain vessels tropism and cytotoxic effects, and impaired microvessel remodeling and angiogenesis [20] that differentially activate mitochondrial apoptotic pathways [21].”
BackgroundResultA computer image analysis system for microvessel density measurement in solid tumours
Goddard, J. C., Sutton, C. D., Furness, P. N., Kockelbergh, R. C., & O'Byrne, K. J. (2002) · Angiogenesis · doi:10.1023/a:1021518315757 · Cited by 37 · cited 1×
“Measuring the MVD is not without limitations, which include a lack of standardization and reliance on the operator to minimize bias leading to the loss of objectiveness [63].”
BackgroundParis, D., Ait‐Ghezala, G., Mathura, V. S., Patel, N. S., Quadros, A., Laporte, V., & Mullan, M. (2005) · Molecular Brain Research · doi:10.1016/j.molbrainres.2005.02.011 · Cited by 37
Vascular Endothelial Barrier Dysfunction Mediated by Amyloid-β Proteins
Nagababu, E., Usatyuk, P. V., Enika, D., Natarajan, V., & Rifkind, J. M. (2009) · Journal of Alzheimer's Disease · doi:10.3233/jad-2009-1104 · Cited by 32 · cited 2×
“In these studies, abeta induced reactive oxygen species (ROS) was ruled out as a potential cause of BBB leakiness because the presence of ROS detoxifying enzymes did not influence abeta induced damage [51].”
BackgroundConverging Perturbed Microvasculature and Microglial Clusters Characterize Alzheimer Disease Brain
Jantaratnotai, N., Schwab, C., K. Ryu, J., L. McGeer, P., & G. McLarnon, J. (2010) · Current Alzheimer Research · doi:10.2174/156720510793499039 · Cited by 26 · cited 4×
“Human brain tissues were stained using methods described by [34].”
BackgroundMethodInfluentialη-Secretase: Reduction of Amyloid Precursor Protein η-Site Cleavage in Alzheimers Disease
Kametani, F. (2008) · Current Alzheimer Research · doi:10.2174/156720508783954776 · Cited by 19
Quantitative analysis of angiogenesis using confocal laser scanning microscopy
Guo, L., Burke, P., Lo, S. H., Gandour‐Edwards, R. F., & Lau, D. H. (2001) · Angiogenesis · doi:10.1023/a:1014010801754 · Cited by 17 · cited 1×
“[37] with minor modifications.”
Research works printed but not linked: 1
- MM Verbeek, 1997, The role of amyloid in the pathogenesis of Alzheimer's disease., Biol Chem, 378, 937
Cited by
Mechanisms of sporadic cerebral small vessel disease: insights from neuroimaging
Wardlaw, J. M., Smith, C., & Dichgans, M. (2013) · The Lancet Neurology · doi:10.1016/s1474-4422(13)70060-7 · Cited by 1,657
Alzheimer’s disease: A matter of blood–brain barrier dysfunction?
Montagne, A., Zhao, Z., & Zlokovic, B. V. (2017) · Journal of Experimental Medicine · doi:10.1084/jem.20171406 · Cited by 672
“…of exogenous tracers 4 and 10 mo Cortex Ujiie et al., 2003 Loss of BBB tight junctionsa,d 18 and 24 mo; not studied before 18 mo Cortex, hippocampus Biron et al., 2011 Loss of LRP1 endothelial expression 4 and 6 mo Cortex, hippocampus, thalamus Deane et al., 2004 Increased RAGE vascular…”
BackgroundThe vascular basement membrane in the healthy and pathological brain
Thomsen, M. S., Routhe, L. J., & Moos, T. (2017) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x17722436 · Cited by 490
“This would gradually lead to vessel wall rigidity and reduced cerebral blood flow, hence creating the basis for accumulation of Ab and subsequent CAA and capillary sprouting.(115,145) The reduced cerebral blood flowwas further correlated to the accumulation of Ab in the AD brain.”
BackgroundKent, S. A., Spires-Jones, T. L., & Durrant, C. S. (2020) · Acta Neuropathologica · doi:10.1007/s00401-020-02196-w · Cited by 446
Neurological Diseases in Relation to the Blood–Brain Barrier
Rosenberg, G. A. (2012) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2011.197 · Cited by 445
“In a study in transgenic mice with genes for the familial form of Alzheimer’s disease, amylodogenesis was found to mediate BBB disruption and leakiness through promoting neoangiogenesis and hypervascularity by causing a redistribution of tight junction proteins (Figure 6) (Biron et al, 2011).”
Background
Metadata
- Authors
- Biron, K. E., Dickstein, D. L., Gopaul, R., & Jefferies, W. A.
- Affiliations
- University of British Columbia (CA)
- Icahn School of Medicine at Mount Sinai (US)
- Corresponding author
- Biron, Kaan E.
- Dickstein, Dara L.
- Gopaul, Rayshad
- Jefferies, Wilfred A.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2011-08-31
- Volume
- 6
- Issue
- 8
- Pages
- e23789
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC3166122
- OpenAlex
- W2063038783
- Cited by
- 300
- References
- 73
- Citations by year
- 2026: 15 · 2025: 19 · 2024: 18 · 2023: 18 · 2022: 25 · 2021: 31 · 2020: 29 · 2019: 11 · 2018: 17 · 2017: 14 · 2016: 20 · 2015: 20 · 2014: 26 · 2013: 22 · 2012: 14
- FWCI
- 11.13
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Canadian Institutes of Health Research
- Topics
- Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
- Keywords
- Alzheimer's disease, amyloidogenesis, cerebral angiogenesis, blood-brain barrier permeability, hypervascularity, tight junctions, occludin, ZO-1, cerebrovascular integrity, vascular remodeling, neovascularization
- MeSH terms
- Aging, Alzheimer Disease, Amyloid, Animals, Blood-Brain Barrier, Brain, Female, Humans, Male, Mice, Transgenic, Neovascularization, Pathologic, Permeability, Signal Transduction, Apoptosis, Tight Junctions, Mice, Microvessels
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.